Page 3 - Emcure

Sanofi India, Emcure Pharma announce exclusive distribution partnership

Collaboration aligns with Sanofi's growth strategy in India, named 'India for India', aims to accelerate growth across its pharmaceuticals, specialty care, consumer healthcare, and vaccines business

Emcure Pharmaceuticals refiles IPO papers to Sebi, trims issue size

The company had first submitted draft papers for its IPO in August 2021

Emcure Pharma plans $400-500 mn IPO in 2024; hires JP Morgan, Jefferies

Emcure, backed by private equity firm Bain Capital, has hired investment banks JP Morgan, Jefferies and Kotak for the IPO, and is targeting a valuation of about $3 billion

Gennova's mRNA vaccine in legal storm after HDT Bio Corp sues Emcure

The US firm HDT Bio Corp has alleged that Emcure 'willfully and maliciously' violated the Defend Trade Secrets Act and Washington's laws against trade secret theft

Emcure Pharma to launch oral Covid drug for emergency use in India

Emcure Pharmaceuticals Ltd announced that it has received Emergency Use Authorisation approval for launch of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild Covid-19.

Gennova's mRNA-based Covid vaccine gets nod for Phase 2/3 clinical trials

Gennova's mRNA-based Covid vaccine development programme was partly funded by the DBT under Ind CEPI in June 2020

Emcure strengthens board by including 4 new independent directors

Emcure Pharmaceuticals on Tuesday said it has strengthened its board with the inclusion of four new independent directors, including former Foreign Secretary Vijay Keshav Gokhale. The others who have joined the company's board are Shailesh Ayyangar, Hitesh Jain and Vidya Yeravdekar. Earlier this year, Berjis Desai had taken over as the chairman of Emcure Board. The company has had a long-standing tradition of appointing a Chairman from amongst its independent directors since 1997. "We are delighted to have highly accomplished industry stalwarts as part of our board. New members' combined experience and wider perspective from their respective fields, will play an instrumental role in strengthening our strategic operations to grow in domestic and international markets," Emcure Pharmaceuticals Managing Director & CEO Satish Mehta said in a statement. The drug firm aims to further augment its strengths as one of the fastest growing pharmaceutical companies in India with a global reach

Emcure launches generic breast cancer drug 40% cheaper than innovator's

Emcure plans to capture 25 per cent of the market for the drug as well as expand the market through this cheaper alternative to the innovator drug

2 ex-executives of Emcure's US arm accused of price fixing

Jeffrey Glazer and Jason Malek are also charged with rigging bids and price collusion

US FDA warns Emcure Pharma, cites repeated data fudging at plant

Regulator writes to the firm on 'significant violations' of manufacturing practices at the company' s Pune plant